300.79 USD
▲+4.50+3.00%
盘后 292.04 0.00%
2026-08-03
市值
$5.96B
市盈率
40.11
EPS
7.50
股息率
—
52 周区间
131.67 – 326.63
成交量
329.15K
Beta
0.98
目标价
327.40
52W 低 131.6752W 高 326.63
价格走势
公司简介
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteopor...